Evaluation of new deferasirox-derived compounds for the treatment of iron overload

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Comparative efficacy of iron chelation therapies in thalassemia major: a randomized controlled trial2025
2. 2Impact on overall and progression-free survivals of iron chelation given 6 months after allogeneic hematopoietic stem cell transplantation for Acute Myeloid Leukemia and myelodysplastic syndrom2025
3. 3The Efficacy and Safety of Deferasirox Monotherapy as a Second-Line Treatment in Transfusion-Dependent Thalassemia with Iron Overload2025
4. 4Efficacy of combination chelation with deferasirox and deferiprone in children with beta-thalassemia major: an audit from a unit in the developing world2025
5. 5Bridging Pharmacokinetics and Pharmacodynamics: A <scp>PBPK</scp>/<scp>PD</scp> Model‐Based Approach for Deferasirox Dosing in Transfusion‐Dependent Thalassemia2025 · 1 citations